| Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial HI Brunner, N Ruperto, Z Zuber, C Keane, O Harari, A Kenwright, P Lu, ... Annals of the rheumatic diseases 74 (6), 1110-1117, 2015 | 309 | 2015 |
| Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study A Consolaro, G Giancane, A Alongi, EHP van Dijkhuizen, A Aggarwal, ... The Lancet Child & Adolescent Health 3 (4), 255-263, 2019 | 160 | 2019 |
| Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial HI Brunner, N Ruperto, N Tzaribachev, G Horneff, VG Chasnyk, ... Annals of the rheumatic diseases 77 (1), 21-29, 2018 | 113 | 2018 |
| Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study N Ruperto, HI Brunner, Z Zuber, N Tzaribachev, DJ Kingsbury, I Foeldvari, ... Pediatric Rheumatology 15, 1-10, 2017 | 76 | 2017 |
| Kaleidoscope of autoimmune diseases in HIV infection J Roszkiewicz, E Smolewska Rheumatology international 36, 1481-1491, 2016 | 70 | 2016 |
| Apoptosis of peripheral blood lymphocytes in patients with juvenile idiopathic arthritis E Smolewska, H Brozik, P Smolewski, M Biernacka-Zielinska, ... Annals of the rheumatic diseases 62 (8), 761-763, 2003 | 49 | 2003 |
| Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis E Smolewska, J Stańczyk, H Brózik, M Biernacka-Zielińska, B Cebula, ... Annals of the rheumatic diseases 67 (6), 762-768, 2008 | 41 | 2008 |
| Paediatric Rheumatology International Trials Organisation PRINTO HI Brunner, N Ruperto, Z Zuber, C Keane, O Harari, A Kenwright, P Lu, ... Pediatric Rheumatology Collaborative Study Group (PRCSG). Efficacy and …, 2015 | 36 | 2015 |
| Reactive oxygen species and serum antioxidant defense in juvenile idiopathic arthritis J Lipińska, S Lipińska, J Stańczyk, A Sarniak, A Przymińska vel Prymont, ... Clinical Rheumatology 34, 451-456, 2015 | 31 | 2015 |
| A fresh look at angiogenesis in juvenile idiopathic arthritis J Świdrowska-Jaros, E Smolewska Central European Journal of Immunology 43 (3), 325-330, 2018 | 30 | 2018 |
| Anti-MCV and anti-CCP antibodies—diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA) J Lipinska, S Lipinska, M Kasielski, E Smolewska Clinical rheumatology 35, 2699-2706, 2016 | 27 | 2016 |
| Inhibited apoptosis of synovial fluid lymphocytes in children with juvenile idiopathic arthritis is associated with increased expression of myeloid cell leukemia 1 and XIAP … E Smolewska, J Stanczyk, T Robak, P Smolewski The Journal of rheumatology 33 (8), 1684-1690, 2006 | 24 | 2006 |
| Nailfold capillaroscopy assessment of microcirculation abnormalities and endothelial dysfunction in children with primary or secondary Raynaud syndrome J Latuskiewicz-Potemska, A Chmura-Skirlinska, RJ Gurbiel, E Smolewska Clinical rheumatology 35, 1993-2001, 2016 | 21 | 2016 |
| Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial AV Ramanan, P Quartier, N Okamoto, I Foeldvari, A Spindler, ... The Lancet 402 (10401), 555-570, 2023 | 19 | 2023 |
| Tocilizumab in the treatment of systemic-onset juvenile idiopathic arthritis–single-centre experience J Roszkiewicz, K Orczyk, E Smolewska Reumatologia/Rheumatology 56 (5), 279-284, 2018 | 19 | 2018 |
| Serum Angiogenesis Markers and Their Correlation with Ultrasound‐Detected Synovitis in Juvenile Idiopathic Arthritis J Świdrowska, P Smolewski, J Stańczyk, E Smolewska Journal of Immunology Research 2015 (1), 741457, 2015 | 18 | 2015 |
| Clinical immunology Anti-CCP antibodies in children with Juvenile Idiopathic Arthritis (JIA)–diagnostic and clinical significance J Lipińska, E Smolewska, H Brózik, J Stańczyk Central European Journal of Immunology 33 (1), 19-23, 2008 | 18 | 2008 |
| and the Pediatric Rheumatology Collaborative Study Group (PRCSG). Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis … HI Brunner, N Ruperto, Z Zuber, C Keane, O Harari, A Kenwright, P Lu, ... Ann Rheum Dis 74 (6), 1110-1117, 2015 | 17 | 2015 |
| Imbalance of Th17 and T-regulatory cells in peripheral blood and synovial fluid in treatment naïve children with juvenile idiopathic arthritis J Szymańska-Kałuża, BB CeBula-oBrzut, P SmolewSki, J Stanczyk, ... Central European Journal of Immunology 39 (1), 71-76, 2014 | 17 | 2014 |
| Risk factors of a severe course of pediatric multi-system inflammatory syndrome temporally associated with COVID-19 A Stasiak, E Perdas, E Smolewska European journal of pediatrics 181 (10), 3733-3738, 2022 | 16 | 2022 |
